Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Talecris Plasma Resources is a leading plasma collection company and a subsidiary of Grifols. The company operates a vast network of plasma donor centers across the United States, dedicated to collecting high-quality human plasma through the process of plasmapheresis. This plasma is used as the essential raw material for the production of life-saving therapies that treat rare, chronic, and often genetic diseases, including primary immunodeficiency, hemophilia, and genetic emphysema. Talecris focuses on donor safety and strict regulatory compliance to ensure a consistent supply of plasma for the global healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Talecris Plasma Resources.